Trial · NCT06081244
Registered outcomes20
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 20
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | pathological complete remission (pCR) | at surgery | no invasive tumour in breast and lymph nodes (ypT0/is and ypN0) |
| Primary | invasive disease-free survival rate (iDFS), | after 3 years | time from date of first diagnosis to any invasive breast cancer event, death or secondary malignancy according to STEEP 2.0 criteria |
| Secondary | Overall survival (OS) | 6 years | time from first diagnosis to death |
| Secondary | distant disease-free survival (dDFS) | after 3 years | distant disease-free survival |
| Secondary | distant disease-free interval (dDFI) | after 3 years | distant disease-free interval |
| Secondary | recurrence-free survival (RFS) | after 3 years | recurrence-free survival |
| Secondary | local recurrence-free survival (LRFS) | after 3 years | local recurrence-free survival |
| Secondary | Breast cancer free interval (BCFI) | after 3 years | Breast cancer free interval |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire C30 | Baseline to end of cycle 2 (each cycle is 21 days) | change in QLQ-C30-Score; min 0 - max 100 points; the higher the better quality of life |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire BR45 | Baseline to end of cycle 2 (each cycle is 21 days) | change in BR45-Score; min 0 - max 100 points; the higher points on functional scale the better the function; the higher points on symptom scale the higher the symptomatology. |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire C30 | Baseline to end of cycle 4 (each cycle is 21 days) | change in QLQ-C30-Score; min 0 - max 100 points; the higher the better quality of life |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire BR45 | Baseline to end of cycle 4 (each cycle is 21 days) | change in BR45-Score; min 0 - max 100 points; the higher points on functional scale the better the function; the higher points on symptom scale the higher the symptomatology. |
| Secondary | Health-related QoL: EORTC QLQ-C30 | Baseline to end of cycle 6 (each cycle is 21 days) | change in QLQ-C30-Score; min 0 - max 100 points; the higher the better quality of life |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire BR45 | Baseline to end of cycle 6 (each cycle is 21 days) | change in BR45-Score; min 0 - max 100 points; the higher points on functional scale the better the function; the higher points on symptom scale the higher the symptomatology. |
| Secondary | Health-related QoL: EORTC QLQ-C30 | Baseline to timepoint before surgery | change in QLQ-C30-Score; min 0 - max 100 points; the higher the better quality of life |
| Secondary | Health-related QoL: EORTC QLQ-BR45 | Baseline to timepoint before surgery | change in QLQ-BR45-Score |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire C30 | Baseline to timepoint 1 year after surgery | change in QLQ-C30-Score; min 0 - max 100 points; the higher the better quality of life |
| Secondary | Health-related Quality of Life: Quality of Life Questionnaire BR45 | Baseline to timepoint 1 year after surgery | change in BR45-Score; min 0 - max 100 points; the higher points on functional scale the better the function; the higher points on symptom scale the higher the symptomatology. |
| Other | Other pCR-definitions | at time of surgery | ypT0/is, any ypN * ypT0, ypN0 * near pCR (ypT1a/is, any ypN) |
| Other | stromal tumour infiltrating lymphocytes (sTIL) | at baseline and after 3 weeks of therapy | percentage of sTIL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06081244/registered